Aldosterone to Renin ratio in a primary care setting: the Bussolengo study

The Journal of Clinical Endocrinology and Metabolism
Oliviero OlivieriGianstefano Blengio

Abstract

The aim of the study was to evaluate the prevalence of hypertension associated with an elevated aldosterone to renin activity ratio (ARR) in a sample of adults aged 35-74 yr, randomly selected from the population register of the Bussolengo Health District (northern Italy) and representative of the total population of the district. Subjects (n = 1462) were randomly selected from the population register and examined by their general practitioners. Complete data for 1348 individuals were available for final statistical analysis. Apart from verapamil or alpha-blockers, no hypotensive drugs were allowed during the 4 wk before assay. Direct active renin and aldosterone were measured in the plasma of hypertensive patients after 2 h in the upright posture. Of 412 identified hypertensive patients, 287 subjects agreed to give blood (70% response rate). An aldosterone to active renin ratio (AARR) of 32 pg/ml was taken as the cut-off value, equivalent to an ARR of 50 ng/dl/ng/ml.h. An elevated AARR was observed in 32.4% of the hypertensive patients, with increased prevalence in females and in people aged 55 yr or older. As an elevated AARR is frequent in the general hypertensive population, screening should not be limited to the patients r...Continue Reading

Associated Clinical Trials

Feb 28, 2018·Gian Paolo Rossi, MD, FAHA, FACC

Citations

Feb 1, 2011·Reviews in Endocrine & Metabolic Disorders·Paolo MulateroFranco Veglio
Mar 23, 2011·Reviews in Endocrine & Metabolic Disorders·Yoshiyu TakedaTakashi Yoneda
Apr 6, 2005·Trends in Endocrinology and Metabolism : TEM·Richard D GordonJohn W Funder
Apr 6, 2005·Trends in Endocrinology and Metabolism : TEM·Paolo MulateroPaul M Stewart
Apr 6, 2005·Trends in Endocrinology and Metabolism : TEM·GianPaolo RossiJohn W Funder
Jun 26, 2013·Trends in Endocrinology and Metabolism : TEM·Sandi-Jo GalatiAlice C Levine
Aug 26, 2006·Nature Clinical Practice. Nephrology·Cecilia Mattsson, William F Young
May 26, 2011·Nature Reviews. Endocrinology·Gian Paolo Rossi
Feb 28, 2008·Journal of Hypertension·Oliviero OlivieriRoberto Corrocher
Jun 12, 2009·Journal of Hypertension·Pieter M JansenAnton H van den Meiracker
Dec 3, 2009·Journal of Hypertension·Francesca PizzoloOliviero Olivieri
Mar 13, 2010·Journal of Hypertension·Alberto Morganti, UNKNOWN European study group for the validation of DiaSorin LIAISON Direct Renin Assay
Jul 2, 2011·Journal of Hypertension·John J SimStephen F Derose
Jul 6, 2006·Endocrine Journal·Kinshi KosakaKosei Hirakawa
Jul 6, 2007·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·John W Funder
Feb 15, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Ching-Chu LuUNKNOWN TAIPAI Study Group
Aug 29, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chikako NakamaHiromi Rakugi
Jul 11, 2006·Der Internist·M Quinkler, M Reincke
Dec 23, 2008·Der Internist·E Born-Frontsberg, M Quinkler
Oct 23, 2015·Endocrine Journal·Yukiko TabuchiIichiro Shimomura
Jan 15, 2011·International Journal of Hypertension·Anastasios MakrisDimitris P Papadopoulos
Apr 17, 2015·Journal of Human Hypertension·Q LuoY Jia
May 12, 2007·Clinical Endocrinology·William F Young
May 19, 2011·Proteomics. Clinical Applications·Annalisa CastagnaDaniela Cecconi
May 4, 2011·European Journal of Clinical Investigation·Aggeliki GouliGeorgios Piaditis
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·John W Funder
Sep 19, 2006·Best Practice & Research. Clinical Endocrinology & Metabolism·Caroline Schirpenbach, Martin Reincke
May 25, 2013·Annals of Medicine·Chia-Ter ChaoMichael Stowasser
Dec 3, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Flavie DerletDamien Gruson
Oct 26, 2011·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·D GrusonA Persu
Oct 14, 2008·Molecular and Cellular Endocrinology·Eleanor DaviesJohn M C Connell
Dec 13, 2006·Journal of the American College of Cardiology·Gian Paolo RossiUNKNOWN PAPY Study Investigators
Dec 30, 2014·European Journal of Endocrinology·George PiaditisGregory Kaltsas
Dec 1, 2007·American Journal of Hypertension·Francesca PizzoloOliviero Olivieri
Apr 6, 2012·American Journal of Hypertension·Michihiro SatohYutaka Imai
Jul 30, 2015·Archives of Endocrinology and Metabolism·Mariela Leal ReynaEster M Pardes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.